Information de reference pour ce titreAccession Number: | 00002953-200906000-00025.
|
Author: | Kalluri, Meena MD; Sahn, Steven A. MD, FCCP; Oddis, Chester V. MD; Gharib, Suzanne L. MD; Christopher-Stine, Lisa MD; Danoff, Sonye K. MD, PhD; Casciola-Rosen, Livia PhD; Hong, Grace MS; Dellaripa, Paul F. MD; Highland, Kristin B. MD
|
Title: | |
Source: | Chest. 135(6):1550-1556, June 2009.
|
Abstract: | Background: The antisynthetase syndrome consists of interstitial lung disease (ILD), arthritis, myositis, fever, mechanic's hands, and Raynaud phenomenon in the presence of an antisynthetase autoantibody, most commonly anti-Jo-1. It is believed that all the antisynthetases are associated with a similar clinical profile, but definitive data in this diverse group are lacking. The purpose of this study was to examine the clinical profile of anti-PL-12, an antisynthetase autoantibody directed against alanyl-transfer RNA synthetase.
Methods: Thirty-one subjects with anti-PL-12 autoantibody were identified from the databases at the Medical University of South Carolina, the University of Pittsburgh Medical Center, Johns Hopkins Medical Center, and Brigham and Women's Hospital. The medical charts were reviewed and the following data were recorded: demographic information; pulmonary and rheumatologic symptoms; connective tissue disease (CTD) diagnoses; serologic autoantibody findings; CT scan results; BAL findings; pulmonary function test results; lung histopathology; and treatment interventions.
Results: The median age at symptom onset was 51 years; 81% were women and 52% were African American. Ninety percent of anti-PL-12-positive patients had ILD, 65% of whom presented initially to a pulmonologist. Ninety percent of anti-PL-12-positive patients had an underlying CTD. Polymyositis and dermatomyositis were the most common underlying diagnoses. Raynaud phenomenon occurred in 65% of patients, fever in 45% of patients, and mechanic's hands in 16% of patients. Test results for the presence of antinuclear antibody were positive in 48% of cases.
Conclusions: Anti-PL-12 is strongly associated with the presence of ILD, but less so with myositis and arthritis. Idiopathic ILD diagnosed as idiopathic pulmonary fibrosis may, in fact, be associated with anti-PL-12 and be a "forme fruste" of an underlying autoimmune disorder.
Copyright (C) 2009 by the American College of Chest Physicians
|
References: | 1 Mimori T, Imura Y, Nakashima R, et al. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007; 19:523-529
2 Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23:881-888
3 Yoshida S, Akizuki M, Mimori T, et al. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26:604-611
4 Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77:1019-1038
5 Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993; 100(suppl):116S-123S
6 Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292:403-407
7 Gerami P, Schope JM, McDonald L, et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006; 54:597-613
8 Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 1999; 210:333-338
9 Ikezoe J, Johkoh T, Kohno N, et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 1996; 11:250-259
10 Stahl NI, Klippel JH, Decker JL. A cutaneous lesion associated with myositis. Ann Intern Med 1979; 91:577-579
11 Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47:614-622
12 American Thoracic Society, European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement. Am J Respir Crit Care Med 2000; 161:646-664
13 Hirakata M. Autoantibodies to aminoacyl-tRNA synthetases. Intern Med 2005; 44:527-528
14 Rubinowitz AN, Moon M, Homer R. A 34-year-old man presenting with gradual onset of shortness of breath and interstitial lung disease. Chest 2008; 133:1041-1047
15 Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991; 70:360-374
16 Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996; 26:459-467
17 Handa T, Nagai S, Kawabata D, et al. Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med 2005; 44:319-325
18 Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990; 88:241-251
19 Hirakata M, Nakamura K, Okano Y, et al. Anti-alanyl tRNA synthetase (PL-12) antibodies are associated with interstitial lung disease in Japanese patients [abstract]. Arthritis Rheum 1995; 38(suppl):S321
20 Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med 1986; 163:1281-1291
21 Arnett FC, Targoff IN, Mimori T, et al. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996; 39:1507-1518
22 Chinoy H, Fertig N, Oddis CV, et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007; 66:1345-1349
23 Osterode W, Rudiger H, Graninger W, et al. Anti-PL 12 and pulmonary fibrosis in a patient ten years after silica/silicate dust exposure. Clin Exp Rheumatol 1998; 16:622
24 Satoh S, Hirakata M, Suwa A, et al. Two cases of interstitial pneumonia with anti-PL-12 (alanyl tRNA synthetase) antibodies [in Japanese]. Ryumachi 1996; 36:862-868
25 Matsushita T, Hasegawa M, Fujimoto M, et al. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 2007; 34:1012-1018
26 Takahashi T, Wada I, Ohtsuka Y, et al. Autoantibody to alanyl-tRNA synthetase in patients with idiopathic pulmonary fibrosis. Respirology 2007; 12:642-653
27 Hengstman GJ, van Engelen BG, Vree Egberts WT, et al. Myositis-specific autoantibodies: overview and recent developments. Curr Opin Rheumatol 2001; 13:476-482
28 Wasicek CA, Reichlin M, Montes M, et al. Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype. Am J Med 1984; 76:538-544
29 Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20:857-880
30 Yoshifuji H, Fuji T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006; 39:233-241
31 La Corte R, Lo Mo Naco A, Locaputo A, et al. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 2006; 39:249-253
32 Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999; 162:2315-2320
33 Bernstein RM, Morgan SH, Chapman J, et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. BMJ (Clin Res Ed) 1984; 289:151-152
|
Language: | English.
|
Document Type: | Original Research: INTERSTITIAL LUNG DISEASE.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0012-3692
|
NLM Journal Code: | 0231335, d1c
|
DOI Number: | https://dx.doi.org/10.1378/chest...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|